Cargando…
An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34(+) cells
BACKGROUND: Transplantation of endothelial progenitor cells (EPCs)/endothelial cells (ECs) has been used for the treatment of ischemic diseases and hemophilia A, due to their great capacity for producing factor VIII and for repairing vascular damage. We established an effective approach to stimulate...
Autores principales: | Qin, Meng, Guan, Xin, Wang, Huihui, Zhang, Yu, Shen, Bin, Zhang, Qingyu, Dai, Wei, Ma, Yupo, Jiang, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297174/ https://www.ncbi.nlm.nih.gov/pubmed/28173870 http://dx.doi.org/10.1186/s13287-017-0482-9 |
Ejemplares similares
-
Evaluation of ex vivo produced endothelial progenitor cells for autologous transplantation in primates
por: Qin, Meng, et al.
Publicado: (2018) -
Large‐Scale Ex Vivo Generation of Human Red Blood Cells from Cord Blood CD34(+) Cells
por: Zhang, Yu, et al.
Publicado: (2017) -
Ex-vivo expansion of nonhuman primate CD34(+) cells by stem cell factor Sall4B
por: Shen, Bin, et al.
Publicado: (2016) -
Safety and efficacy of ex vivo expanded CD34(+) stem cells in murine and primate models
por: Zhang, Yu, et al.
Publicado: (2019) -
Large-scale ex vivo generation of human neutrophils from cord blood CD34(+) cells
por: Jie, Zhenwang, et al.
Publicado: (2017)